Genix Pharmaceuticals Corporation (GENPF)
OTCMKTS · Delayed Price · Currency is USD
0.0141
-0.0159 (-53.00%)
At close: Jan 20, 2026
Genix Pharmaceuticals Revenue
Genix Pharmaceuticals had revenue of 68.00 CAD in the twelve months ending July 31, 2025, down -98.72% year-over-year. In the fiscal year ending October 31, 2024, Genix Pharmaceuticals had annual revenue of 4.05K, down -67.19%.
Revenue (ttm)
68.00 CAD
Revenue Growth
-98.72%
P/S Ratio
18,315.34
Revenue / Employee
0.02 CAD
Employees
4,000
Market Cap
897.45K USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Oct 31, 2024 | 4.05K | -8.30K | -67.19% |
| Oct 31, 2023 | 12.35K | - | - |
| Oct 31, 2022 | - | - | - |
| Oct 31, 2021 | - | - | - |
| Oct 31, 2020 | - | - | - |
| Oct 31, 2019 | 137.40K | -282.56K | -67.28% |
| Oct 31, 2018 | 419.96K | -1.86K | -0.44% |
| Oct 31, 2017 | 421.82K | -502.87K | -54.38% |
| Oct 31, 2016 | 924.70K | 273.84K | 42.07% |
| Oct 31, 2015 | 650.86K | 277.73K | 74.43% |
| Oct 31, 2014 | 373.13K | -221.87K | -37.29% |
| Oct 31, 2013 | 595.00K | -8.11K | -1.34% |
| Oct 31, 2012 | 603.11K | 29.83K | 5.20% |
| Oct 31, 2011 | 573.28K | 284.73K | 98.67% |
| Oct 31, 2010 | 288.56K | -150.79K | -34.32% |
| Oct 31, 2009 | 439.35K | 167.95K | 61.88% |
| Oct 31, 2008 | 271.40K | 70.89K | 35.35% |
| Oct 31, 2007 | 200.51K | -719.75K | -78.21% |
| Oct 31, 2006 | 920.26K | -624.48K | -40.43% |
| Oct 31, 2005 | 1.54M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Tian'an Pharmaceutical | 10.65M |
| Target Group | 5.00M |
| Pure Harvest Corporate Group | 2.48M |
| Cannabis Global | 1.06M |
| Opus Holdings | 758.68K |
| CBD Life Sciences | 178.45K |
| TransGlobal Assets | 91.35K |
| Premier Biomedical | 14.28K |
Genix Pharmaceuticals News
- 4 months ago - Genix Pharmaceuticals Issues Clarification to Previously Announced Private Placement Terms - Newsfile Corp
- 5 months ago - Genix Pharmaceuticals Closes Private Placement - Newsfile Corp
- 2 years ago - Genix Announces TSX-V Approval of Warrant Amendments - Newsfile Corp
- 2 years ago - Genix Announces Warrant Repricing and Seeks Extension - Newsfile Corp
- 2 years ago - Genix Announces AGM Results - Newsfile Corp
- 3 years ago - Genix Receives Approval to Extend Warrants from the TSX Venture Exchange - Newsfile Corp
- 3 years ago - Genix Proposes to Extend Warrants - Newsfile Corp